Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.62 |
---|---|
High | 1.64 |
Low | 1.55 |
Bid | 1.45 |
Offer | 1.62 |
Previous close | 1.58 |
Average volume | 35.01k |
---|---|
Shares outstanding | 16.64m |
Free float | 13.40m |
P/E (TTM) | -- |
Market cap | 26.29m USD |
EPS (TTM) | -0.6679 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Iridex Appoints Patrick Mercer as Chief Executive Officer
- Iridex Reports Second Quarter 2024 Financial Results
- Iridex Announces Convertible Note Financing
- Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
- Iridex Reports First Quarter 2024 Financial Results
- Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
- Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
- Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
- Iridex Corporation Receives European Patent on MicroPulse Technology
- Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
More ▼